The federal government has handed US consulting giant McKinsey a further $1.5 million to provide advice on mRNA vaccines, as the wait continues for a decision on who will deliver a local manufacturing capability. McKinsey has now been paid about $5.7 million this year to produce a business case and advise on the ongoing approach…

The post McKinsey given a further $1.5m by government for mRNA vaccine advice appeared first on InnovationAus.

This post was originally published on InnovationAus.